Literature DB >> 8096434

The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis.

M E Curran1, D L Atkinson, A K Ewart, C A Morris, M F Leppert, M T Keating.   

Abstract

To identify genes involved in vascular disease, we investigated patients with supravalvular aortic stenosis (SVAS), an inherited vascular disorder that causes hemodynamically significant narrowing of large elastic arteries. Pulsed-field gel and Southern analyses showed that a translocation near the elastin gene cosegregated with SVAS in one family. DNA sequence analyses demonstrated that the translocation disrupted the elastin gene and localized the breakpoint to exon 28. Taken together with our previous study linking SVAS to the elastin gene in two additional families and existing knowledge of vascular biology, these data suggest that mutations in the elastin gene can cause SVAS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8096434     DOI: 10.1016/0092-8674(93)90168-p

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  102 in total

1.  Fluorescent in situ hybridisation (FISH) for hemizygous deletion at the elastin locus in patients with isolated supravalvular aortic stenosis.

Authors:  H Fryssira; R Palmer; K A Hallidie-Smith; J Taylor; D Donnai; W Reardon
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  Decreased elastin in vessel walls puts the pressure on.

Authors:  Jeanine D'Armiento
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

3.  Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.

Authors:  A Hinek; S E Wilson
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

4.  Submicroscopic deletion in patients with Williams-Beuren syndrome influences expression levels of the nonhemizygous flanking genes.

Authors:  Giuseppe Merla; Cédric Howald; Charlotte N Henrichsen; Robert Lyle; Carine Wyss; Marie-Thérèse Zabot; Stylianos E Antonarakis; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2006-06-23       Impact factor: 11.025

Review 5.  Dysmorphic disorders--an overview.

Authors:  D Donnai
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Developmental adaptation of the mouse cardiovascular system to elastin haploinsufficiency.

Authors:  Gilles Faury; Mylène Pezet; Russell H Knutsen; Walter A Boyle; Scott P Heximer; Sean E McLean; Robert K Minkes; Kendall J Blumer; Attila Kovacs; Daniel P Kelly; Dean Y Li; Barry Starcher; Robert P Mecham
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

7.  Negative autoregulation of GTF2IRD1 in Williams-Beuren syndrome via a novel DNA binding mechanism.

Authors:  Stephen J Palmer; Nicole Santucci; Jocelyn Widagdo; Sara J Bontempo; Kylie M Taylor; Enoch S E Tay; Jeff Hook; Frances Lemckert; Peter W Gunning; Edna C Hardeman
Journal:  J Biol Chem       Date:  2009-12-09       Impact factor: 5.157

8.  Comparison of TFII-I gene family members deleted in Williams-Beuren syndrome.

Authors:  Timothy A Hinsley; Pamela Cunliffe; Hannah J Tipney; Andrew Brass; May Tassabehji
Journal:  Protein Sci       Date:  2004-10       Impact factor: 6.725

Review 9.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

10.  Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: evaluation of 235 patients.

Authors:  M C Lowery; C A Morris; A Ewart; L J Brothman; X L Zhu; C O Leonard; J C Carey; M Keating; A R Brothman
Journal:  Am J Hum Genet       Date:  1995-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.